Proteinase-activated receptor-2-mediated activation of stress-activated protein kinases and inhibitory kappa B kinases in NCTC 2544 keratinocytes
about
Proteinase-activated receptor-2 mediated inhibition of TNFalpha-stimulated JNK activation - A novel paradigm for G(q/11) linked GPCRsSerratia marcescens serralysin induces inflammatory responses through protease-activated receptor 2The emergence of proteinase-activated receptor-2 as a novel target for the treatment of inflammation-related CNS disordersCUX1 transcription factor is a downstream effector of the proteinase-activated receptor 2 (PAR2)Protease-activated receptor 2 signalling promotes dendritic cell antigen transport and T-cell activation in vivoProtease activated receptor signaling is required for African trypanosome traversal of human brain microvascular endothelial cellsNovel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo.Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluationSarsasapogenin-AA13 inhibits LPS-induced inflammatory responses in macrophage cells in vitro and relieves dimethylbenzene-induced ear edema in miceNon-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesisPaneth cell trypsin is the processing enzyme for human defensin-5.Protease-activated receptor (PAR)2, but not PAR1, is involved in collateral formation and anti-inflammatory monocyte polarization in a mouse hind limb ischemia model.Essential role for proteinase-activated receptor-2 in arthritis.PAR(2) expression in peripheral blood monocytes of patients with rheumatoid arthritis.Protease-activated receptor-2 (PAR-2) is a weak enhancer of mucin secretion by human bronchial epithelial cells in vitro.Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.Biased signaling of protease-activated receptors.The role of intracellular Ca2+ in the regulation of proteinase-activated receptor-2 mediated nuclear factor kappa B signalling in keratinocytes.Differential Activation of Human Keratinocytes by Leishmania Species Causing Localized or Disseminated Disease.Hepatocyte growth factor activator inhibitor type 1 maintains the assembly of keratin into desmosomes in keratinocytes by regulating protease-activated receptor 2-dependent p38 signaling.Inhibition of protein kinase C attenuates Pseudomonas aeruginosa elastase-induced epithelial barrier disruption.Dual effect of the novel peptide antagonist K-14585 on proteinase-activated receptor-2-mediated signalling.Phospholipase Cdelta1 is required for skin stem cell lineage commitment.A novel secreted protease from Pseudomonas aeruginosa activates NF-kappaB through protease-activated receptors.Role of proteinase-activated receptor-2 on cyclooxygenase-2 expression in H. pylori-infected gastric epithelial cells.The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes/macrophages.Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2.Agonists of proteinase-activated receptor 2 induce TNF-alpha secretion from astrocytoma cells.Tissue factor/factor VIIa signalling promotes cytokine-induced beta cell death and impairs glucose-stimulated insulin secretion from human pancreatic islets.Cytokine upregulation of proteinase-activated-receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase beta in human endothelial cells.Infection of microglia with Porphyromonas gingivalis promotes cell migration and an inflammatory response through the gingipain-mediated activation of protease-activated receptor-2 in mice.Novel role for proteinase-activated receptor 2 (PAR2) in membrane trafficking of proteinase-activated receptor 4 (PAR4).p38 mitogen-activated protein kinase inhibits calcium-dependent chloride secretion in T84 colonic epithelial cells.Correlation of protease-activated receptor-2 expression and synovitis in rheumatoid and osteoarthritis.Lack of effect of proteinase-activated receptor-2 (PAR-2) deletion on the pathophysiological changes produced by lipopolysaccharide in the mouse: comparison with dexamethasone.Protease-Mediated Suppression of DRG Neuron Excitability by Commensal Bacteria.Abnormalities of hair structure and skin histology derived from CRISPR/Cas9-based knockout of phospholipase C-delta 1 in mice.
P2860
Q24318701-7FC8945A-B5B2-4332-BB45-3AF6BBB56220Q24678788-38F232E0-CEEB-4E71-95B3-CC61F4250D68Q24679499-48D2C2D1-B9B9-4853-B0F9-704603768C4FQ28298716-F8909FD3-DA12-44D9-ABE4-4F44BCD74C3AQ28511351-EEF14DCA-008B-4E80-9F02-A77A46C3EF00Q33484728-3C551176-759D-47F2-9DE5-DD3D0EA315AFQ33498642-B4C20127-CE69-4E1C-8A17-C93986C946D1Q33694183-D305DFDA-983B-426B-94B9-0CB4DBDB1C3EQ33759949-192618E4-BCBB-45D8-82A4-F73C37D1CE1BQ33955272-97F9699B-F84F-4377-B6F2-AD97985A1A29Q34129474-A6A268C6-1D56-4AF3-B1FC-92CB9E35A19EQ34700750-A30C286B-CDB0-4444-9FB8-5C5B0D8C92D9Q34828059-7262A762-0248-492D-87D8-73747C8BF764Q36884133-AB090548-7207-45C6-85A0-556021A03D6DQ36961061-84397B3F-2174-4493-AE04-2B86665879C8Q37024500-0D07FA5C-B9F8-475A-A27E-2F91C80FF198Q38214613-B7F2E86B-15D8-4EBC-BAF2-AF39255A3825Q38328187-F9F0F0CE-6663-4F33-B6CD-D4792F9A7F9DQ38710622-2C4D0183-D14A-475F-AF73-60C493D073BAQ38890925-01D49C01-CCD2-4F10-AEC5-1677E44B2FEBQ39506558-CD3D797F-499D-4019-AF5B-16A0C745779DQ39774017-F5E17AE1-0149-4E95-9743-ECC7D282DB90Q39777505-DAC8613C-2FDA-495E-AD47-14D7A0D2351FQ40003955-CDDD8AB4-C4C2-4361-8B5A-B1A653A6FA55Q40150248-5AB545A3-F5D8-4531-B9F0-38B5ED285E18Q40246157-C3043B25-42F0-42E7-AB91-A940D944942BQ40447234-0C6BA202-2121-4753-B396-1C6682D4E183Q40692317-BADC97BC-D4CE-4002-8459-C02E4E7DC6F1Q41553743-F7D8A757-527E-4FAA-BDBD-7297D1ABE230Q41585571-01951053-249A-482A-816A-BBE7AFC5C795Q41717940-A6B79D21-E717-4AA9-B7FE-407FBCCA5DB1Q42061332-5020D4C2-3659-44B7-85D5-28A9ED643D12Q44185266-F40CA3DC-350D-47FB-BDA2-56CA381F443AQ44432812-916FA0F2-DAA1-4894-AED2-7C90EA11E51CQ45001402-2E1DC836-7B7F-4AD7-A527-663DA470F4DCQ46271336-0B5FBBF7-B95B-483C-A201-C76AC936022DQ54984258-F97DC4B8-7991-4165-B39C-A118A89860B0
P2860
Proteinase-activated receptor-2-mediated activation of stress-activated protein kinases and inhibitory kappa B kinases in NCTC 2544 keratinocytes
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Proteinase-activated receptor- ...... ses in NCTC 2544 keratinocytes
@ast
Proteinase-activated receptor- ...... ses in NCTC 2544 keratinocytes
@en
Proteinase-activated receptor- ...... ses in NCTC 2544 keratinocytes
@en-gb
Proteinase-activated receptor- ...... ses in NCTC 2544 keratinocytes
@nl
type
label
Proteinase-activated receptor- ...... ses in NCTC 2544 keratinocytes
@ast
Proteinase-activated receptor- ...... ses in NCTC 2544 keratinocytes
@en
Proteinase-activated receptor- ...... ses in NCTC 2544 keratinocytes
@en-gb
Proteinase-activated receptor- ...... ses in NCTC 2544 keratinocytes
@nl
prefLabel
Proteinase-activated receptor- ...... ses in NCTC 2544 keratinocytes
@ast
Proteinase-activated receptor- ...... ses in NCTC 2544 keratinocytes
@en
Proteinase-activated receptor- ...... ses in NCTC 2544 keratinocytes
@en-gb
Proteinase-activated receptor- ...... ses in NCTC 2544 keratinocytes
@nl
P2093
P2860
P356
P1476
Proteinase-activated receptor- ...... ses in NCTC 2544 keratinocytes
@en
P2093
E Davenport
M J Seatter
R C McKenzie
S R Macfarlane
P2860
P304
P356
10.1074/JBC.M100377200
P407
P577
2001-08-24T00:00:00Z